129 related articles for article (PubMed ID: 29793797)
1. Effect of blood transfusions on oncological outcomes of surgically treated localized renal cell carcinoma.
Tsivian M; Abern MR; Tsivian E; Sze C; Jibara G; Rampersaud EN; Polascik TJ
Urol Oncol; 2018 Aug; 36(8):362.e1-362.e7. PubMed ID: 29793797
[TBL] [Abstract][Full Text] [Related]
2. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
[TBL] [Abstract][Full Text] [Related]
3. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma.
Abu-Ghanem Y; Zilberman DE; Dotan Z; Kaver I; Ramon J
Urol Oncol; 2018 Jan; 36(1):12.e15-12.e20. PubMed ID: 28993059
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.
Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
Int J Clin Oncol; 2020 Aug; 25(8):1551-1561. PubMed ID: 32504136
[TBL] [Abstract][Full Text] [Related]
5. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
Linder BJ; Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Gastineau DA; Boorjian SA
BJU Int; 2014 Sep; 114(3):368-74. PubMed ID: 24471825
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma.
Abu-Ghanem Y; Dotan Z; Zilberman DE; Kaver I; Ramon J
Sci Rep; 2019 Feb; 9(1):1160. PubMed ID: 30718860
[TBL] [Abstract][Full Text] [Related]
7. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
9. Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.
Iwata T; Kimura S; Foerster B; Abufaraj M; Karakiewicz PI; Preisser F; Nasu Y; Shariat SF
Urol Oncol; 2019 Apr; 37(4):273-281. PubMed ID: 30737159
[TBL] [Abstract][Full Text] [Related]
10. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
11. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
[TBL] [Abstract][Full Text] [Related]
12. The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK; Boorjian SA
Urol Oncol; 2015 Sep; 33(9):388.e11-8. PubMed ID: 25700974
[TBL] [Abstract][Full Text] [Related]
13. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
14. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
[TBL] [Abstract][Full Text] [Related]
15. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
16. Blood loss and the need for transfusion in patients who undergo partial or radical nephrectomy for renal cell carcinoma.
Shvarts O; Tsui KH; Smith RB; Kernion JB; Belldegrun A
J Urol; 2000 Oct; 164(4):1160-3. PubMed ID: 10992357
[TBL] [Abstract][Full Text] [Related]
17. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.
Qi P; Tsivian M; Abern MR; Passoni NM; McGinley KF; Polascik TJ
Urol Oncol; 2014 Jul; 32(5):555-60. PubMed ID: 24495445
[TBL] [Abstract][Full Text] [Related]
19. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
